The CNS can be a safe space for CARs
- PMID: 31515225
- DOI: 10.1182/blood.2019002506
The CNS can be a safe space for CARs
Conflict of interest statement
Conflict-of-interest disclosure: C.A.R. has participated in advisory board meetings for Novartis and Celgene and has research funding from Tessa Therapeutics.
Comment on
-
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.Blood. 2019 Sep 12;134(11):860-866. doi: 10.1182/blood.2019001694. Epub 2019 Jul 18. Blood. 2019. PMID: 31320380 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical

